Maitreya Medica.

{
  "main_header": {
    "sid": 10039066,
    "name": "Maitreya Medica.",
    "stock_name": "Maitreya Medica.",
    "full_name": "Maitreya Medicare Ltd",
    "name_url": "stocks-analysis/maitreya-medica",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "218.00",
    "chg": 3.85,
    "chgp": "1.8%",
    "dir": 1,
    "prev_price": "214.15",
    "mcapval": "148.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "MAITREYA",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0PLQ01011",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": 1600,
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/maitreya-medica-10039066-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Maitreya Medicare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/maitreya-medicare-ltd-is-rated-strong-sell-3781554",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MaitreyaMedicar_mojoScore_3781554.png",
        "date": "2026-01-05 10:11:38",
        "description": "Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Why is Maitreya Medicare Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-maitreya-medicare-ltd-fallingrising-3771778",
        "imagepath": "",
        "date": "2025-12-27 00:51:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Stock Performance Against Benchmarks</strong></p>\n<p>Over the past year, Maitreya Medicare has delivered a disappointing return of -34.37%, starkly contrasting with the Sensex’s positive gain of 9.65% during the same period. The stock’s underperformance extends beyond the one-year horizon, with a year-to-date loss of 37.51% compared to the Sensex’s 10.14% rise. Even in the short term, the stock has declined by 6.93% in the last week, while the benchmark index edged up by 0.29%. This persistent lagging performance highlights the market’s lack of confidence in the company’s prospects.</p>\n<p><strong>Technical Indicators and Market Sentiment</strong></p>\n<p>On the technical front, Maitreya Medicare is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-d..."
      },
      {
        "title": "Maitreya Medicare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/maitreya-medicare-ltd-is-rated-strong-sell-3769817",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MaitreyaMedicar_mojoScore_3769817.png",
        "date": "2025-12-25 15:12:28",
        "description": "Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insight into the company’s performance and outlook."
      },
      {
        "title": "Maitreya Medica. Sees Revision in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/maitreya-medica-downgraded-to-strong-sell-by-marketsmojo-amid-deteriorating-fundamentals-3746499",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MaitreyaMedica_mojoScore_3746499.png",
        "date": "2025-12-04 11:08:19",
        "description": "Maitreya Medica., a microcap player in the hospital sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance from market analysts."
      },
      {
        "title": "How has been the historical performance of Maitreya Medica.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-maitreya-medica-3726458",
        "imagepath": "",
        "date": "2025-11-24 23:30:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Trends</strong></p>\n<p>Examining the consolidated net sales from March 2022 to March 2025, Maitreya Medica's revenue has shown some volatility. The company recorded net sales of ₹49.41 crores in March 2022, which declined to ₹39.38 crores in March 2023 before partially recovering to ₹46.66 crores by March 2025. This indicates a challenging period in 2023, followed by a stabilisation in the subsequent years.</p>\n<p>Operating profit margins excluding other income peaked at 18.41% in March 2023 but declined to 10.42% by March 2025, signalling pressure on operational efficiency. Similarly, the profit after tax (PAT) margin followed a downward trend from 10.79% in 2023 to 4.01% in 2025, reflecting reduced net profitability.</p>\n<p>Profit after tax figures also mirror this patte..."
      },
      {
        "title": "Maitreya Medicare Quality Parameter Revision: A Detailed Analysis of Business Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/maitreya-medicare-quality-grade-downgrade-a-detailed-analysis-of-business-fundamentals-3714085",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MaitreyaMedicar_qualitydot_3714085.png",
        "date": "2025-11-19 08:00:33",
        "description": "Maitreya Medicare, a player in the hospital sector, has undergone a revision in its quality parameter evaluation, shifting from an average to a below average grade. This adjustment reflects changes in key business fundamentals such as return on equity (ROE), return on capital employed (ROCE), debt levels, and growth metrics, which are critical for investors analysing the company’s financial health and operational consistency."
      },
      {
        "title": "How has been the historical performance of Maitreya Medica.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-maitreya-medica-3713256",
        "imagepath": "",
        "date": "2025-11-18 23:03:12",
        "description": "Answer:\nThe historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years.\n\nBreakdown:\nMaitreya Medica's net sales have seen a decline from INR 49.41 crore in March 2022 to INR 46.66 crore in March 2025, with a peak of INR 47.80 crore in March 2024. Total operating income mirrored this trend, peaking in March 2024 before dropping to INR 46.66 crore in March 2025. The company's operating profit (PBDIT) also decreased from INR 7.82 crore in March 2023 to INR 5.45 crore in March 2025, reflecting a decline in operating profit margin from 18.41% to 10.42%. Profit before tax followed a similar downward trajectory, falling from INR 5.93 crore in March 2023 to INR 3.21 crore in March 2025. Consequently, profit after tax decreased from INR 4.25 crore in March 2023 to INR 1.87 crore in March 2025, resulting in a PAT margin decline from 10.79% to 4.01%. On the balance s..."
      },
      {
        "title": "Why is Maitreya Medica. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-maitreya-medica-fallingrising-3709446",
        "imagepath": "",
        "date": "2025-11-18 00:05:52",
        "description": "As of 17-Nov, Maitreya Medicare Ltd's stock price is currently at 260.55, reflecting a decline of 26.0 points or 9.07%. The stock has underperformed its sector today by 11.49%, despite showing higher performance than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. Over the past week, the stock has gained 9.80%, but it has experienced a significant year-to-date decline of 22.49%. The company's ability to service debt is strong, indicated by a low Debt to EBITDA ratio of 0.30 times, and it has an attractive valuation with a Price to Book Value of 5.5. However, the stock's profits have fallen by 40% over the past year, contributing to its negative return of 21.97%.\n\nIn the broader market context, Maitreya Medicare Ltd's performance over the past week has outpaced the Sensex, which has only increased by 1.72%. However, the stock's year-to-date perfor..."
      },
      {
        "title": "How has been the historical performance of Maitreya Medica.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-maitreya-medica-3704272",
        "imagepath": "",
        "date": "2025-11-15 00:31:30",
        "description": "Answer:\nThe historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years.\n\nBreakdown:\nMaitreya Medica's net sales decreased slightly from INR 47.80 crore in March 2024 to INR 46.66 crore in March 2025, following a peak of INR 49.41 crore in March 2022 and a lower figure of INR 39.38 crore in March 2023. The total operating income mirrored this trend, remaining at INR 46.66 crore in March 2025. The total expenditure, excluding depreciation, decreased to INR 41.80 crore in March 2025 from INR 42.09 crore in March 2024. Operating profit (PBDIT) fell to INR 5.45 crore in March 2025 from INR 5.98 crore in the previous year, with a notable decline from INR 7.82 crore in March 2023. Profit before tax also decreased to INR 3.21 crore in March 2025, down from INR 3.90 crore in March 2024 and INR 5.93 crore in March 2023. Consequently, profit after tax dropped to INR ..."
      }
    ],
    "total": 107,
    "sid": "10039066",
    "stock_news_url": "https://www.marketsmojo.com/news/maitreya-medicare-10039066"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Maitreya Medicare Ltd is Rated Strong Sell

2026-01-05 10:11:38

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Why is Maitreya Medicare Ltd falling/rising?

2025-12-27 00:51:57

Stock Performance Against Benchmarks

Over the past year, Maitreya Medicare has delivered a disappointing return of -34.37%, starkly contrasting with the Sensex’s positive gain of 9.65% during the same period. The stock’s underperformance extends beyond the one-year horizon, with a year-to-date loss of 37.51% compared to the Sensex’s 10.14% rise. Even in the short term, the stock has declined by 6.93% in the last week, while the benchmark index edged up by 0.29%. This persistent lagging performance highlights the market’s lack of confidence in the company’s prospects.

Technical Indicators and Market Sentiment

On the technical front, Maitreya Medicare is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-d...

Read full news article

Maitreya Medicare Ltd is Rated Strong Sell

2025-12-25 15:12:28

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insight into the company’s performance and outlook.

Read full news article

Maitreya Medica. Sees Revision in Market Assessment Amid Mixed Financial Signals

2025-12-04 11:08:19

Maitreya Medica., a microcap player in the hospital sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance from market analysts.

Read full news article

How has been the historical performance of Maitreya Medica.?

2025-11-24 23:30:02

Revenue and Profit Trends

Examining the consolidated net sales from March 2022 to March 2025, Maitreya Medica's revenue has shown some volatility. The company recorded net sales of ₹49.41 crores in March 2022, which declined to ₹39.38 crores in March 2023 before partially recovering to ₹46.66 crores by March 2025. This indicates a challenging period in 2023, followed by a stabilisation in the subsequent years.

Operating profit margins excluding other income peaked at 18.41% in March 2023 but declined to 10.42% by March 2025, signalling pressure on operational efficiency. Similarly, the profit after tax (PAT) margin followed a downward trend from 10.79% in 2023 to 4.01% in 2025, reflecting reduced net profitability.

Profit after tax figures also mirror this patte...

Read full news article

Maitreya Medicare Quality Parameter Revision: A Detailed Analysis of Business Fundamentals

2025-11-19 08:00:33

Maitreya Medicare, a player in the hospital sector, has undergone a revision in its quality parameter evaluation, shifting from an average to a below average grade. This adjustment reflects changes in key business fundamentals such as return on equity (ROE), return on capital employed (ROCE), debt levels, and growth metrics, which are critical for investors analysing the company’s financial health and operational consistency.

Read full news article

How has been the historical performance of Maitreya Medica.?

2025-11-18 23:03:12

Answer: The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales have seen a decline from INR 49.41 crore in March 2022 to INR 46.66 crore in March 2025, with a peak of INR 47.80 crore in March 2024. Total operating income mirrored this trend, peaking in March 2024 before dropping to INR 46.66 crore in March 2025. The company's operating profit (PBDIT) also decreased from INR 7.82 crore in March 2023 to INR 5.45 crore in March 2025, reflecting a decline in operating profit margin from 18.41% to 10.42%. Profit before tax followed a similar downward trajectory, falling from INR 5.93 crore in March 2023 to INR 3.21 crore in March 2025. Consequently, profit after tax decreased from INR 4.25 crore in March 2023 to INR 1.87 crore in March 2025, resulting in a PAT margin decline from 10.79% to 4.01%. On the balance s...

Read full news article

Why is Maitreya Medica. falling/rising?

2025-11-18 00:05:52

As of 17-Nov, Maitreya Medicare Ltd's stock price is currently at 260.55, reflecting a decline of 26.0 points or 9.07%. The stock has underperformed its sector today by 11.49%, despite showing higher performance than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. Over the past week, the stock has gained 9.80%, but it has experienced a significant year-to-date decline of 22.49%. The company's ability to service debt is strong, indicated by a low Debt to EBITDA ratio of 0.30 times, and it has an attractive valuation with a Price to Book Value of 5.5. However, the stock's profits have fallen by 40% over the past year, contributing to its negative return of 21.97%. In the broader market context, Maitreya Medicare Ltd's performance over the past week has outpaced the Sensex, which has only increased by 1.72%. However, the stock's year-to-date perfor...

Read full news article

How has been the historical performance of Maitreya Medica.?

2025-11-15 00:31:30

Answer: The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales decreased slightly from INR 47.80 crore in March 2024 to INR 46.66 crore in March 2025, following a peak of INR 49.41 crore in March 2022 and a lower figure of INR 39.38 crore in March 2023. The total operating income mirrored this trend, remaining at INR 46.66 crore in March 2025. The total expenditure, excluding depreciation, decreased to INR 41.80 crore in March 2025 from INR 42.09 crore in March 2024. Operating profit (PBDIT) fell to INR 5.45 crore in March 2025 from INR 5.98 crore in the previous year, with a notable decline from INR 7.82 crore in March 2023. Profit before tax also decreased to INR 3.21 crore in March 2025, down from INR 3.90 crore in March 2024 and INR 5.93 crore in March 2023. Consequently, profit after tax dropped to INR ...

Read full news article

View All News